JP2005511482A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005511482A5 JP2005511482A5 JP2002586732A JP2002586732A JP2005511482A5 JP 2005511482 A5 JP2005511482 A5 JP 2005511482A5 JP 2002586732 A JP2002586732 A JP 2002586732A JP 2002586732 A JP2002586732 A JP 2002586732A JP 2005511482 A5 JP2005511482 A5 JP 2005511482A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- protonated compound
- antimicrobial composition
- composition
- alkenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 12
- 230000000845 anti-microbial Effects 0.000 claims 9
- 125000003342 alkenyl group Chemical group 0.000 claims 4
- 125000000217 alkyl group Chemical group 0.000 claims 4
- 125000003118 aryl group Chemical group 0.000 claims 4
- 239000002981 blocking agent Substances 0.000 claims 4
- 125000005741 alkyl alkenyl group Chemical group 0.000 claims 3
- 125000002877 alkyl aryl group Chemical group 0.000 claims 3
- 125000005018 aryl alkenyl group Chemical group 0.000 claims 3
- 230000001588 bifunctional Effects 0.000 claims 3
- 230000000249 desinfective Effects 0.000 claims 3
- 239000004599 antimicrobial Substances 0.000 claims 2
- 230000000903 blocking Effects 0.000 claims 2
- 206010060945 Bacterial infection Diseases 0.000 claims 1
- 230000000844 anti-bacterial Effects 0.000 claims 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 239000003974 emollient agent Substances 0.000 claims 1
- 239000003995 emulsifying agent Substances 0.000 claims 1
- 125000002587 enol group Chemical group 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- 239000000314 lubricant Substances 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol Chemical group OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 239000002562 thickening agent Substances 0.000 claims 1
- 239000000080 wetting agent Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/847,654 US20020032164A1 (en) | 1998-12-30 | 2001-05-03 | Antimicrobial compounds and methods for their use |
| PCT/US2002/013910 WO2002089581A1 (en) | 2001-05-03 | 2002-05-03 | Antimicrobial compounds and methods for their use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009120362A Division JP5503900B2 (ja) | 2001-05-03 | 2009-05-18 | 抗菌化合物およびそれらの使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005511482A JP2005511482A (ja) | 2005-04-28 |
| JP2005511482A5 true JP2005511482A5 (US06780888-20040824-C00057.png) | 2005-12-22 |
| JP4347573B2 JP4347573B2 (ja) | 2009-10-21 |
Family
ID=25301163
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002586732A Expired - Fee Related JP4347573B2 (ja) | 2001-05-03 | 2002-05-03 | 抗菌組成物、細菌感染症を治療するための方法、及び消毒用組成物 |
| JP2009120362A Expired - Fee Related JP5503900B2 (ja) | 2001-05-03 | 2009-05-18 | 抗菌化合物およびそれらの使用方法 |
| JP2013210031A Expired - Fee Related JP5883838B2 (ja) | 2001-05-03 | 2013-10-07 | 抗菌化合物およびそれらの使用方法 |
| JP2015219286A Expired - Fee Related JP6097372B2 (ja) | 2001-05-03 | 2015-11-09 | 抗菌化合物およびそれらの使用方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009120362A Expired - Fee Related JP5503900B2 (ja) | 2001-05-03 | 2009-05-18 | 抗菌化合物およびそれらの使用方法 |
| JP2013210031A Expired - Fee Related JP5883838B2 (ja) | 2001-05-03 | 2013-10-07 | 抗菌化合物およびそれらの使用方法 |
| JP2015219286A Expired - Fee Related JP6097372B2 (ja) | 2001-05-03 | 2015-11-09 | 抗菌化合物およびそれらの使用方法 |
Country Status (10)
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6627215B1 (en) * | 1998-12-30 | 2003-09-30 | Oligos Etc. Inc. | Devices for improved wound management |
| US20020032164A1 (en) * | 1998-12-30 | 2002-03-14 | Dale Roderic M. K. | Antimicrobial compounds and methods for their use |
| US7868162B2 (en) * | 1998-12-30 | 2011-01-11 | Lakewood-Amedex, Inc. | Antimicrobial and antiviral compounds and methods for their use |
| EP2351765A3 (en) * | 2001-07-10 | 2012-02-22 | Lakewood-Amedex, Inc | Oligonucleotide-containing pharmacological compositions and their use |
| US8785403B2 (en) | 2003-08-01 | 2014-07-22 | Mitsubishi Tanabe Pharma Corporation | Glucopyranoside compound |
| WO2005011592A2 (en) * | 2003-08-01 | 2005-02-10 | Janssen Pharmaceutica N.V. | Substituted indazole-o-glucosides |
| AR045173A1 (es) | 2003-08-01 | 2005-10-19 | Tanabe Seiyaku Co | Compuestos que poseen actividad inhibitoria contra transportador de glucosa dependiente de sodio |
| TW200727785A (en) * | 2005-11-25 | 2007-08-01 | Maruishi Pharma | Gel composition for antibacterial sterilization |
| UY30730A1 (es) * | 2006-12-04 | 2008-07-03 | Mitsubishi Tanabe Pharma Corp | Forma cristalina del hemihidrato de 1-(b (beta)-d-glucopiranosil) -4-metil-3-[5-(4-fluorofenil) -2-tienilmetil]benceno |
| ES2675045T3 (es) * | 2007-05-04 | 2018-07-06 | Symrise Ag | Preparaciones activas sinérgicas que comprenden 1,2-decanodiol y además compuestos activos antimicrobianos |
| WO2009035969A1 (en) * | 2007-09-10 | 2009-03-19 | Janssen Pharmaceutica N.V. | Process for the preparation of compounds useful as inhibitors of sglt |
| CL2008003653A1 (es) | 2008-01-17 | 2010-03-05 | Mitsubishi Tanabe Pharma Corp | Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica. |
| GB2460445B (en) * | 2008-05-30 | 2012-07-11 | Vernolix Ltd | Treatment of ringworm |
| US9056850B2 (en) * | 2008-10-17 | 2015-06-16 | Janssen Pharmaceutica N.V. | Process for the preparation of compounds useful as inhibitors of SGLT |
| US20110009347A1 (en) | 2009-07-08 | 2011-01-13 | Yin Liang | Combination therapy for the treatment of diabetes |
| EP2451797B1 (en) | 2009-07-10 | 2013-04-03 | Janssen Pharmaceutica, N.V. | CRYSTALLISATION PROCESS FOR 1-(ß-D-GLUCOPYRANOSYL)-4-METHYL-3-[5-(4-FLUOROPHENYL)-2-THIENYLMETHYL]BENZENE |
| WO2011047113A1 (en) * | 2009-10-14 | 2011-04-21 | Janssen Pharmaceutica Nv | Process for the preparation of compounds useful as inhibitors of sglt2 |
| CN108354930A (zh) | 2010-05-11 | 2018-08-03 | 詹森药业有限公司 | 包含1-(β-D-吡喃葡萄糖基)-2-噻吩基-甲基苯衍生物的药物制剂 |
| HUE030116T2 (en) | 2011-04-13 | 2017-04-28 | Janssen Pharmaceutica Nv | A method for preparing compounds useful as inhibitors of SGLT2 |
| TWI542596B (zh) | 2011-05-09 | 2016-07-21 | 健生藥品公司 | （２ｓ,３ｒ,４ｒ,５ｓ,６ｒ）－２－（３－（（５－（４－氟苯基）噻吩－２－基）甲基）－４－甲基苯基）－６－（羥甲基）四氫－２ｈ－哌喃－３,４,５－三醇之ｌ－脯胺酸及檸檬酸共晶體 |
| US20170071970A1 (en) | 2015-09-15 | 2017-03-16 | Janssen Pharmaceutica Nv | Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders |
| BR112019018615B1 (pt) | 2017-03-10 | 2021-11-16 | Lakewood Amedex, Inc. | Composto antimicrobiano e sua composiqao farmaceutica |
| US11795192B2 (en) | 2017-03-10 | 2023-10-24 | Lakewood Amedex, Inc. | Antimicrobial compounds, compositions, and uses thereof |
| US11377468B2 (en) | 2017-03-10 | 2022-07-05 | Lakewood Amedex, Inc. | Antimicrobial compounds, compositions, and uses thereof |
| EP3638251B1 (en) | 2017-06-12 | 2024-03-06 | Lakewood Amedex, Inc. | Bisphosphocin gel formulations and uses thereof |
| EP3641725A1 (en) | 2017-06-23 | 2020-04-29 | The Procter and Gamble Company | Composition and method for improving the appearance of skin |
| EP3817717A1 (en) | 2018-07-03 | 2021-05-12 | The Procter & Gamble Company | Method of treating a skin condition |
| AU2019361999A1 (en) | 2018-10-17 | 2021-02-25 | Lakewood Amedex, Inc. | Methods and compositions for treating oral mucositis |
| CZ308943B6 (cs) * | 2019-12-12 | 2021-09-22 | Ústav organické chemie a biochemie AV ČR, v. v. i. | Lipofosfonoxiny třetí generace, jejich příprava a použití |
| JP2023528616A (ja) | 2020-06-01 | 2023-07-05 | ザ プロクター アンド ギャンブル カンパニー | ビタミンｂ３化合物の皮膚への浸透を改善する方法 |
| US10959933B1 (en) | 2020-06-01 | 2021-03-30 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
| KR20220009630A (ko) * | 2020-07-16 | 2022-01-25 | 정준영 | 플라즈마를 이용한 마스크 폐기 처리기 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4105782A (en) | 1975-03-07 | 1978-08-08 | Yu Ruey J | Treatment of acne and dandruff |
| DE2916318A1 (de) * | 1979-04-23 | 1980-11-06 | Hoechst Ag | Waesserige desinfektionsloesung |
| US4421769A (en) | 1981-09-29 | 1983-12-20 | The Procter & Gamble Company | Skin conditioning composition |
| US4908209A (en) * | 1983-08-16 | 1990-03-13 | Interface, Inc. | Biocidal delivery system of phosphate ester and method of preparation thereof |
| JPS60209077A (ja) * | 1984-03-27 | 1985-10-21 | 竹本油脂株式会社 | 繊維処理用油剤及び該油剤による合成繊維糸の処理方法 |
| US4897355A (en) | 1985-01-07 | 1990-01-30 | Syntex (U.S.A.) Inc. | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| DE3542516A1 (de) | 1985-12-02 | 1987-06-04 | Henkel Kgaa | Desinfektionsmittel |
| WO1989001023A1 (en) * | 1987-08-03 | 1989-02-09 | Interface Research Corporation | Microbiocidal cleansing or disinfecting formulations and preparation thereof |
| US5153000A (en) * | 1988-11-22 | 1992-10-06 | Kao Corporation | Phosphate, liposome comprising the phosphate as membrane constituent, and cosmetic and liposome preparation comprising the liposome |
| ZA902710B (en) | 1989-05-22 | 1991-12-24 | Univ Georgia Res Found | Enzyme luminescence assay |
| US5153230A (en) | 1989-10-06 | 1992-10-06 | Perfective Cosmetics, Inc. | Topical skin cream composition |
| US5264618A (en) | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
| WO1991017424A1 (en) | 1990-05-03 | 1991-11-14 | Vical, Inc. | Intracellular delivery of biologically active substances by means of self-assembling lipid complexes |
| US5420330A (en) * | 1990-09-07 | 1995-05-30 | Pharmacia P-L Biochemicals Inc. | Lipo-phosphoramidites |
| WO1992010504A2 (en) * | 1990-12-07 | 1992-06-25 | The Upjohn Company | Phosphonic acid derivatives useful as antiinflammatory agents |
| US5681829A (en) * | 1992-10-08 | 1997-10-28 | Shaman Pharmaceuticals, Inc. | Class of phosphocholine derivatives having antifungal activity |
| US5811568A (en) * | 1992-10-08 | 1998-09-22 | Shaman Pharmaceuticals, Inc. | Process for the preparation of mono- and bis(phosphocholine) derivatives which have antifungal activity |
| AU5354494A (en) * | 1992-10-08 | 1994-05-09 | Shaman Pharmaceuticals, Inc. | Novel class of phosphocholine derivatives having antifungal activity |
| DE4333385C2 (de) | 1993-09-30 | 1997-01-30 | Friedrich A Spruegel | Flächendesinfektions- und Reinigungsmittel |
| FR2718022B1 (fr) | 1994-04-01 | 1996-04-26 | Roussel Uclaf | Compositions cosmétiques ou dermatologiques et leur préparation. |
| FR2727289B1 (fr) * | 1994-11-30 | 1999-03-05 | Derives Resiniques Terpenique | Composition desinfectante comprenant au moins un alcool terpenique et au moins un tensio-actif acide bactericide, et utilisation de tels tensio-actifs |
| CA2238484A1 (en) * | 1995-11-28 | 1997-06-05 | Michael D. Wider | Antimicrobial composition and methods of use therefor |
| US5843998A (en) | 1997-06-30 | 1998-12-01 | Song; Jin | Skin blemish treatment |
| US20020032164A1 (en) * | 1998-12-30 | 2002-03-14 | Dale Roderic M. K. | Antimicrobial compounds and methods for their use |
| US6211349B1 (en) * | 1998-12-30 | 2001-04-03 | Oligos Etc., Inc. | Protonated/acidified nucleic acids and methods of use |
| US6610314B2 (en) * | 2001-03-12 | 2003-08-26 | Kimberly-Clark Worldwide, Inc. | Antimicrobial formulations |
-
2001
- 2001-05-03 US US09/847,654 patent/US20020032164A1/en not_active Abandoned
-
2002
- 2002-05-03 EP EP10184218.5A patent/EP2311466B1/en not_active Expired - Lifetime
- 2002-05-03 CA CA2445381A patent/CA2445381C/en not_active Expired - Fee Related
- 2002-05-03 PT PT101842185T patent/PT2311466E/pt unknown
- 2002-05-03 WO PCT/US2002/013910 patent/WO2002089581A1/en active Application Filing
- 2002-05-03 AU AU2002305336A patent/AU2002305336B2/en not_active Ceased
- 2002-05-03 ES ES10184218.5T patent/ES2549766T3/es not_active Expired - Lifetime
- 2002-05-03 DK DK10184218.5T patent/DK2311466T3/en active
- 2002-05-03 CA CA2827671A patent/CA2827671C/en not_active Expired - Fee Related
- 2002-05-03 JP JP2002586732A patent/JP4347573B2/ja not_active Expired - Fee Related
- 2002-05-03 EP EP02734149A patent/EP1389909B1/en not_active Expired - Lifetime
-
2004
- 2004-09-08 US US10/937,094 patent/US7176191B2/en not_active Expired - Lifetime
-
2009
- 2009-05-18 JP JP2009120362A patent/JP5503900B2/ja not_active Expired - Fee Related
-
2013
- 2013-10-07 JP JP2013210031A patent/JP5883838B2/ja not_active Expired - Fee Related
-
2015
- 2015-10-08 CY CY20151100909T patent/CY1116784T1/el unknown
- 2015-11-09 JP JP2015219286A patent/JP6097372B2/ja not_active Expired - Fee Related
